Detalhe da pesquisa
1.
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients.
J Asthma
; : 1-26, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578082
2.
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Respir Res
; 24(1): 135, 2023 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210543
3.
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
Respir Res
; 23(1): 36, 2022 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35183167
4.
Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis.
Allergy
; 77(1): 150-161, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978983
5.
Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis.
Crit Care
; 25(1): 268, 2021 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330320
6.
Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma.
Pulm Pharmacol Ther
; 64: 101966, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039666
7.
Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.
Pulm Pharmacol Ther
; 60: 101874, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857207
8.
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia.
Clin Exp Rheumatol
; 38(6): 1215-1222, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275095
9.
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.
BMC Infect Dis
; 20(1): 748, 2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050889
10.
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation.
Crit Care
; 24(1): 589, 2020 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32993751
11.
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.
Respirology
; 25(5): 543-551, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385399
12.
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life.
Pulm Pharmacol Ther
; 54: 87-89, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597278
13.
One year of mepolizumab. Efficacy and safety in real-life in Italy.
Pulm Pharmacol Ther
; 58: 101836, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473366
14.
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.
BMC Infect Dis
; 18(1): 677, 2018 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563504
15.
Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: Results from the Italian Severe Asthma Registry.
Allergy
; 76(3): 902-905, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794585
16.
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
Allergy
; 76(3): 871-874, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716580
17.
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.
Allergy
; 75(6): 1460-1463, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31773742
18.
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation.
Allergy
; 74(12): 2539-2541, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166605
19.
Tezepelumab: patient selection and place in therapy in severe asthma.
J Int Med Res
; 52(4): 3000605241246740, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676539
20.
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence.
Expert Opin Biol Ther
; 24(1-2): 15-23, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197326